Search results
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 13 hours agoShanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
No Best Nutrition Strategy for Most Preemies Waiting to Breastfeed
MedPage Today· 1 day agoFor infants born between 32 and 35 weeks 6 days' gestation -- comprising 85% of all preemies ...
Generative AI gold rush drives IT spending — with payoff in question
CIO· 6 days agoWorldwide IT spending should grow by 8% this year, with AI hype and COVID-era device replacements...
The pandemic cost 7 million lives, but talks to prevent a repeat stall
Washington Post· 4 days agoIn late 2021, as the world reeled from the arrival of the highly contagious omicron variant of the...
15 Countries with the Highest Life Expectancy in Asia
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will look at the 15 countries with the highest life expectancy in Asia. If you...
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
Zacks· 1 day agoThe earnings season is in full swing now with several MedTech bigwigs already releasing first-quarter results. Per the latest Earnings Preview, quarterly results of the Medical sector have declined ...
Chronic Myelogenous Leukemia (CML): 5 Things to Know
Medscape· 2 days agoAdvanced and emerging therapies in CML offer significantly improved survival. These five things to know will help elucidate potential pitfalls and pearls...
Deadly opioids smuggled into UK in dog food, BBC learns
BBC via Yahoo News· 3 days agoExperts say this increases the risk of overdose, with users unknowingly taking powerful opioids,...
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275...
FOX 4 Kansas City· 5 hours agoPerrigo Company plc (NYSE PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that pharmaceutical company Esteve Healthcare, S.L. ("ESTEVE" ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 hours agoProjected return on investment in pharma research and development (R&D) in 2023 has risen to 4.1%, climbing back from 2022's record low of 1.2%. Total sales revenue for the leading 20 global ...
